Buy & Sell State Street SPDR S&P Biotech ETF (XBI) – State Street SPDR S&P Biotech ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- Broad Market / FactorSector
- -8.57%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 21 daysTypical Hold Time
Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $82.93 and a high of $155.29, highlighting its annual price range. Over the past three months, State Street SPDR S&P Biotech ETF has recorded a drawdown of -8.57%, reflecting recent price volatility. On average, investors hold State Street SPDR S&P Biotech ETF for approximately 21 days, indicating typical investor behavior on the platform.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
Investors in Putnam mutual funds may claim compensation over alleged misleading info by Putnam Investment Management.
The Rosen Law Firm has announced an investigation into Putnam Investment Management, LLC for potentially issuing misleading business information to investors in its stock-based mutual funds. Investors who purchased these funds might be eligible for c...

Conagra's 10% dividend yield may be cut under new CEO amid slowing growth and heavy debt.
Conagra Brands, known for its high 10% dividend yield, faces uncertainty as its new CEO takes charge. The company is dealing with slowing growth and significant debt, prompting investors to worry about a potential dividend cut. The new CEO may priori...

Investors in Strategy Inc. may claim compensation over alleged misleading info in securities.
The Rosen Law Firm has announced an investigation into potential securities claims for shareholders of Strategy Inc. due to allegations that the company provided materially misleading business information. Investors who purchased Strategy securities ...
